GlassScriptPhysician profile
Tammy L Chorak
NPI 1902213986
$727.41
in general payments reported to CMS, 2019-2025
18 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $194 · 2023: $108 · 2024: $237 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $157.74 | 2023-2024 | |
| Abbvie INC. | $100.44 | 2022-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $73.46 | 2022-2023 | Entyvio |
| Averitas Pharma INC. | $54.61 | 2024 | Qutenza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $52.14 | 2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $37.81 | 2024-2025 | Uzedy, Austedo Xr |
| Janssen Pharmaceuticals, INC | $30.25 | 2025 | Spravato |
| Axsome Therapeutics, INC. | $30.14 | 2025 | Auvelity |
| Janssen Biotech, INC. | $28.49 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $27.73 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $22.05 | 2025 | Cobenfy |
| Gilead Sciences, INC. | $19.69 | 2022 | |
| Vanda Pharmaceuticals INC. | $19.46 | 2025 | Fanapt, Hetlioz |
| Baxter Healthcare | $15.80 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Madrigal Pharmaceuticals | $15.07 | 2024 | Resmetirom |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $15.06 | 2023 | Mounjaro, Trulicity |
| Corcept Therapeutics | $13.98 | 2022 | |
| Nestle Healthcare Nutrition INC. | $13.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tammy Chorak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.